The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
作者信息
Sweet R D, McDowell F H
出版信息
Adv Neurol. 1974;5:331-8.
PMID:4440581
Abstract
摘要
相似文献
1
The "on-off" response to chronic L-DOPA treatment of Parkinsonism.帕金森病患者对慢性左旋多巴治疗的“开-关”反应。
Adv Neurol. 1974;5:331-8.
2
Variations in the "on-off" phenomenon.“开-关”现象的变异
Adv Neurol. 1974;5:339-40.
3
The "on-off" side effect of L-DOPA.左旋多巴的“开-关”副作用。
Adv Neurol. 1974;5:387-96.
4
Short- and long-term approaches to the "on-off" phenomenon.“开-关”现象的短期和长期应对方法。
Adv Neurol. 1974;5:379-86.
5
[Risks in the treatment of parkinsonism with l-dopa and a dopa decarboxylase inhibitor].[左旋多巴与多巴脱羧酶抑制剂治疗帕金森病的风险]
Med Welt. 1979 Nov 16;30(46):1740-2.
6
The "on-off" effect.“开-关”效应。
Adv Neurol. 1974;5:367-8.
7
L-dopa, parkinsonism, and involuntary movements.左旋多巴、帕金森症与不自主运动。
Trans Am Neurol Assoc. 1974;99:163-6.
8
Modification of Parkinsonism--chronic treatment with L-dopa.帕金森病的改善——左旋多巴的长期治疗
N Engl J Med. 1969 Feb 13;280(7):337-45. doi: 10.1056/NEJM196902132800701.
9
[Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].[左旋多巴与左旋多巴脱羧酶抑制剂联合治疗219例帕金森综合征3至5年的结果]
Rev Neurol (Paris). 1974 Jul-Aug;130(7-8):273-84.
10
[Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].[左旋多巴单独治疗及左旋多巴与多巴脱羧酶抑制剂联合治疗的长期治疗方面]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1982 Oct-Dec;27(4):261-70.
引用本文的文献
1
Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC-HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel.采用 LC-HRMS 对健康人体参与者血浆中的 foslevodopa/foscarbidopa 进行代谢物分析，结果表明与给予左旋多巴/卡比多巴肠凝胶相比无明显差异。
Pharmacol Res Perspect. 2024 Apr;12(2):e1190. doi: 10.1002/prp2.1190.
2
[3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.[3H]2-氨基-6,7-二羟基-1,2,3,4-四氢萘（ADTN）。急性和慢性药物治疗后的区域分布及体内结合情况。
Neurochem Res. 1980 Jun;5(6):641-51. doi: 10.1007/BF00964785.
3
Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.伴有“开-关”现象的帕金森综合征的电休克治疗
J Neural Transm. 1980;47(1):11-21. doi: 10.1007/BF01256635.
4
Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms.帕金森病开关现象患者接受电休克治疗后症状改善的预测因素
J Neural Transm. 1981;52(3):199-211. doi: 10.1007/BF01249604.
5
Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.司来吉兰用于左旋多巴治疗的帕金森病患者反应波动的管理
J Neurol Neurosurg Psychiatry. 1980 Nov;43(11):1016-21. doi: 10.1136/jnnp.43.11.1016.
6
"On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.帕金森病的“开-关”现象：与血浆中多巴浓度的相关性
J Neural Transm. 1984;59(3):229-40. doi: 10.1007/BF01250010.
7
Deprenyl in Parkinson disease: personal experience.司来吉兰治疗帕金森病：个人经验
Ital J Neurol Sci. 1985 Jun;6(2):207-12. doi: 10.1007/BF02229194.
8
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism.D2 激动剂 MK-458（羟丙基甲基纤维素）在帕金森病中的药代动力学及剂量比例关系
Clin Pharmacokinet. 1992 Mar;22(3):223-30. doi: 10.2165/00003088-199222030-00004.
9
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.单胺氧化酶-B抑制剂司立吉林增强左旋多巴治疗后的抗运动不能作用。
J Neural Transm. 1975;36(3-4):303-26. doi: 10.1007/BF01253131.
10
Clinical pharmacokinetics of levodopa in parkinson's disease.帕金森病中左旋多巴的临床药代动力学
Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.
Zotero 插件